|Dave, at lunch today, between appointments.|
The upshot is, it's only been two years since the last round of chemo, so another round at this time would have a higher risk than benefit. Just a few years ago, there would be no other options. But a new treatment was just approved 8 months ago: Ibrutinib. It should reduce the cancer cells and their adverse effects, but not right away. Just like the older chemo, it's likely to make him feel worse before he feels better. And it's not without side effects. But it's still better than the alternatives. It's a pill, and he will need to take it for the rest of his life. He's thrilled that he doesn't have to deal with IV infusions again.
The next hurdle is getting our insurance to approve the treatment, and then affording the co-pay. And then obtaining the drug (apparently it has to be shipped here from Texas?) Luckily, Dave's oncologist has a staff person assigned to help us through these issues. We met with her this afternoon and she was very optimistic and reassuring. It might be a week or so before it's all figured out and he actually starts the drug.